UBS initiated coverage on Mettler-Toledo with a new price target
$MTD
Biotechnology: Laboratory Analytical Instruments
Industrials
UBS initiated coverage of Mettler-Toledo with a rating of Neutral and set a new price target of $1,237.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/28/2024 | $1400.00 | Equal Weight | Wells Fargo |
| 6/3/2024 | $1250.00 | Underperform | Jefferies |
| 12/11/2023 | $1050.00 → $975.00 | Neutral → Sell | Citigroup |
| 12/19/2022 | $1100.00 → $1350.00 | Underweight → Neutral | JP Morgan |
| 11/8/2022 | $1120.00 → $1355.00 | Sell → Neutral | Goldman |
| 9/6/2022 | $1500.00 | Hold → Buy | Stifel |
| 7/20/2022 | $1237.00 | Neutral | UBS |
| 4/25/2022 | Equal Weight → Overweight | Wells Fargo |
Goldman Sachs analyst Matthew Sykes maintains Mettler-Toledo Intl (NYSE:MTD) with a Neutral and raises the price target from $1150 to $1300.
Evercore ISI Group analyst Vijay Kumar maintains Mettler-Toledo Intl (NYSE:MTD) with a In-Line and raises the price target from $1375 to $1390.
Mettler-Toledo Intl (NYSE:MTD) has outperformed the market over the past 10 years by 8.63% on an annualized basis producing an average annual return of 19.24%. Currently, Mettler-Toledo Intl has a market capitalization of $30.84 billion. Buying $100 In MTD: If an investor had bought $100 of MTD stock 10 years ago, it would be worth $584.86 today based on a price of $1443.83 for MTD at the time of writing. Mettler-Toledo Intl's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's auto
10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021. Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 1% compared with the prior year. Net earnings per diluted share as reported (EPS) were $9.96, compared with $9.21 in the prior-year period. Adjusted EPS was $10.21, an increase of 4% over the prior-year amount of $9.80. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We experienced good growth during the third quarter in our Laboratory business and had par
Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its third quarter 2024 financial results after the market close on Thursday, November 7, 2024. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and
Mettler-Toledo International Inc. (NYSE:MTD) today announced second quarter results for 2024. Provided below are the highlights: Reported sales declined 4% compared with the prior year. In local currency, sales decreased 2% in the quarter as currency reduced sales growth by 2%. Net earnings per diluted share as reported (EPS) were $10.37, compared with $9.69 in the prior-year period. Adjusted EPS was $9.65, a decrease of 5% over the prior-year amount of $10.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Second Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our team c
Wells Fargo initiated coverage of Mettler-Toledo with a rating of Equal Weight and set a new price target of $1,400.00
Jefferies resumed coverage of Mettler-Toledo with a rating of Underperform and set a new price target of $1,250.00
Citigroup downgraded Mettler-Toledo from Neutral to Sell and set a new price target of $975.00 from $1,050.00 previously
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 1% compared with the prior year. Net earnings per diluted share as reported (EPS) were $9.96, compared with $9.21 in the prior-year period. Adjusted EPS was $10.21, an increase of 4% over the prior-year amount of $9.80. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We experienced good growth during the third quarter in our Laboratory business and had par
Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the UBS Global Healthcare Conference on Wednesday, November 13 at 11 a.m. EST, and the Stifel Healthcare Conference on Tuesday, November 19 at 1:15 p.m. EST. The Company will also present at the 7th Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 9:10 a.m. EST. A live webcast of the presentations will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in mo
Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its third quarter 2024 financial results after the market close on Thursday, November 7, 2024. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)